Product development resource
Tablet Compression Problems: Capping, Lamination, Sticking and Variation
Tablet defects are symptoms of interactions among formulation, granule or blend properties, tooling and press conditions. Troubleshooting should test causes rather than apply one universal fix.
Short answer
Capping, lamination, sticking and weight variation are not single-cause defects. They emerge from the interaction of material properties, granulation or blend quality, moisture, lubrication, tooling, press speed, force history and ejection.
The useful question is not “Which additive fixes capping?” It is “At which stage does the defect appear, what changed, and which material or process mechanism is consistent with the evidence?”
Evidence guide: Published evidence — supported by the linked technical source. · Development guidance — a practical decision or testing framework, not a universal specification. · Manufacturer-specific — depends on the selected site, equipment and commercial arrangement. · Product-specific validation — must be demonstrated with the actual formula, process, pack and market.
Read the defect before changing the formula
| Symptom | What it means visually | Cause families to investigate |
|---|---|---|
| Capping | Top or bottom crown separates | Air entrapment, weak bonding, elastic recovery, tooling or speed |
| Lamination | Tablet separates into layers | Entrapped air, compaction history, formulation or ejection stress |
| Sticking | Material adheres to punch face | Moisture, low-melting/sticky material, lubrication, surface or temperature |
| Picking | Local material pulled from tablet, often near embossing | Local adhesion, engraving, moisture or formulation |
| Binding | Difficult die-wall movement/ejection | Friction, lubrication, moisture or tooling condition |
These are diagnostic starting points, not one-to-one prescriptions.
Formulation and granule causes
Poor compactability, an unsuitable particle-size distribution, too many fines, overly dry or wet granules, insufficient binder, excessive lubricant exposure, elastic ingredients or a sticky active can contribute to defects. Granulation may improve flow and bonding in one formula but create dense, poorly disintegrating granules in another.
Return to the tablet formulation framework: active load, excipient functions, material deformation and the intended disintegration mechanism must remain coherent.
Press and tooling causes
Precompression, main compression force, dwell time, turret speed, feeder settings, fill depth and ejection conditions interact. Increasing force may strengthen a weak tablet, but beyond the useful region it can worsen elastic stress, tooling load or disintegration. Reducing speed can provide more dwell time, but it is not proof that the commercial target rate will work.
Worn or damaged tooling, deep embossing, poor surface finish, temperature rise and alignment also deserve inspection before reformulating.
Weight and content variation
Tablet-weight variation can start with inconsistent die filling caused by poor flow, changing bulk density, feeder behaviour or press speed. Content variation can also arise from inadequate mixing or segregation during transfer and hopper discharge.
A stable average tablet weight does not prove ingredient uniformity. Low-dose actives and blends with mismatched particle properties require risk-based sampling and content-uniformity controls.
Hardness, friability and disintegration are connected
Hardness is not an isolated quality target. Compression and formulation changes that improve mechanical strength may slow liquid penetration or disintegration. A fast-disintegrating tablet that chips in coating or transport is also not acceptable.
Evaluate tensile or crushing strength where appropriate, friability, thickness, weight, disintegration and dissolution together. The desired operating window matters more than maximizing one number.
A structured troubleshooting sequence
- Define when and where the defect appears.
- Confirm raw-material lots, environmental conditions and preceding process data.
- Separate blend/granule, press-setting and tooling hypotheses.
- Change one justified factor or use a designed experiment where appropriate.
- Check downstream consequences, including coating, disintegration and stability.
- Confirm the solution at intended scale and speed.
Document failed hypotheses too; they prevent repetitive trial-and-error.
Sources and evidence boundaries
- Partheniadis, Terzi and Nikolakakis, “Finite Element Analysis and Modeling in Pharmaceutical Tableting,” Pharmaceutics 14 (2022): 673. Full text
- Jakubowska and Ciepluch, “Blend Segregation in Tablets Manufacturing and Its Effect on Drug Content Uniformity—A Review,” Pharmaceutics 13 (2021): 1909. Full text
- Markl and Zeitler, “A Review of Disintegration Mechanisms and Measurement Techniques,” Pharmaceutical Research 34 (2017): 890–917. Full text
- ICH, “Q1A(R2): Stability Testing of New Drug Substances and Products.” Official guideline
The literature supports multi-factor tableting and segregation mechanisms. It does not provide a universal setting or excipient correction for a specific production defect.